Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioenergy Life Science (BLS) is a biotechnology company specializing in the development of functional ingredients for the health and wellness industry. The company is best known for its patented Bioenergy Ribose, a five-carbon sugar that facilitates the body's natural process of energy production by increasing adenosine triphosphate (ATP) levels. BLS focuses on applications in sports nutrition, cardiovascular health, and metabolic support. Their product portfolio has expanded to include other branded ingredients like RiaGev, which combines ribose with nicotinamide to support NAD+ levels. The company provides scientific research and regulatory support for its ingredients, which are used by global manufacturers in supplements, functional foods, and beverages. BLS is a subsidiary of Chengzhi Life Science and maintains a strong focus on clinical validation and intellectual property.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioenergy.